Project Grant K23AG090699
- Federal Grant Award Summary Award Details: The National Institute on Aging (NIA) awarded Massachusetts General Hospital a $6.76 million Project Grant under the Aging Research program (CFDA 93.866) on September 1, 2025, with completion targeted for August 31, 2029. The award supports a single-blind, randomized controlled trial (Stage 2) evaluating Resilient Together-YOD (RT-YOD), a dyadic resiliency intervention designed for patients with young-onset dementia (YOD) and their care-partners....
- Federal Grant Award Summary Massachusetts General Hospital's Research Management Division received a $679,058 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded July 1, 2026, with a completion date of March 31, 2030. The grant funds a mixed-methods research initiative investigating the clinical impact of Geriatric Emergency Department Accreditation (GEDA) on emergency care processes and outcomes for older adults with Alzheimer's...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $157,760 Project Grant to The General Hospital Corporation (Massachusetts General Hospital) on August 20, 2026, under the Aging Research program (CFDA 93.866) to support investigator-initiated biomedical research. The award funds a one-year research project through August 19, 2027, examining a novel mechanism of autophagic degradation in cellular senescence. The research investigates how ATG8 family proteins facilitate...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Beth Israel Deaconess Medical Center $191,193 on September 9, 2025, under the Aging Research program (CFDA 93.866) to develop and pilot test an Electronic Health Record (EHR)-based Serious Illness Communication intervention for older adults in emergency departments (SIC-ED). Under the direction of Principal Investigator Dr. Adrian Haimovich, the project will create an EHR-embedded, transdisciplinary intervention...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Massachusetts General Hospital $459,250 under the Aging Research program (CFDA 93.866) on June 1, 2025, for a two-year project extending through May 31, 2027. This project grant supports longitudinal research investigating the mechanisms by which stress and resilience influence cognitive aging and Alzheimer's disease (AD) progression. The research will analyze existing data from two natural history,...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Massachusetts General Hospital a Project Grant of $722,746 on February 15, 2026, under the Aging Research program (CFDA 93.866) to conduct a multi-site clinical trial testing the efficacy of the Coma Family Program (COMA-F), a resilience intervention designed to reduce emotional distress in caregivers of patients with severe acute brain injury (SABI). The grant, which extends through January 31, 2031, supports...
- Grant Summary The National Institute on Aging (NIA) awarded Massachusetts General Hospital a $825,000 Project Grant effective September 15, 2025, through August 31, 2027, under the Aging Research program (CFDA 93.866). The project addresses critical communication gaps in palliative care delivery to Latino Spanish-speaking older adults by exploring serious illness communication (SIC)—structured, emotionally supportive conversations about prognosis, values, and care priorities—between patients and...
- Federal Project Grant Award Summary Massachusetts General Hospital's Research Management Division received a $269,452 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded February 18, 2026, with an ultimate completion date of November 30, 2028. The award funds a research project titled "Deciphering Proteomic Aging: From Causal Mechanisms to Frailty Prediction," which will integrate large-scale genetic, multi-omic, and clinical...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $335,880 Project Grant to Boston Children's Hospital on August 15, 2025, under the Aging Research program (CFDA 93.866) to conduct basic neuroscience research aimed at elucidating the molecular mechanisms underlying cognitive resilience to Alzheimer's Disease (AD). The research will extend through May 31, 2030, and focuses on understanding how 10-15% of individuals maintain normal cognition despite high levels of AD...
- Federal Grant Award Summary Massachusetts General Hospital received a $660,000 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective March 15, 2026 through February 28, 2029. The award supports development of deep learning-based computational tools to improve longitudinal structural magnetic resonance imaging (MRI) analysis for Alzheimer's disease diagnosis. Specifically, the project will develop anatomy-aware registration algorithms and...
The National Institute on Aging (NIA) awarded a Project Grant of $197,555 to Massachusetts General Hospital (The General Hospital Corporation) effective July 1, 2026, through June 30, 2031, under the Aging Research program (CFDA 93.866). The award supports the development and optimization of CONNECT (Collaborative Navigation and Nurturing Empathy through Communication Techniques), a structured diagnostic disclosure communication intervention designed to improve clinician communication with patients and caregivers at the time of dementia diagnosis. The intervention integrates person-centered communication practices derived from palliative care, including skills in delivering difficult news, responding to emotions, tailoring messaging to patient and caregiver needs, and partnering in care planning. The project provides career development training to Dr. Joanna Paladino, a palliative care physician-scientist, in three key areas: dementia clinical care and research; theory-driven intervention development and social determinants of health; and clinical trials in dementia care. The initiative builds on Dr. Paladino's prior experience with the Serious Illness Care Program and leverages an expert mentorship team at Massachusetts General Hospital with demonstrated expertise in federally funded clinical trials, dementia, geriatrics, intervention development, and palliative care. The structured intervention is intended to address documented deficiencies in diagnostic disclosure communication and improve outcomes for patients and caregivers receiving a dementia diagnosis.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $197.6k | 7/3/26 |